Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials

Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials

Abstract Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to lower the risk of re-hospitalization and cardiovascular mortality among heart failure (HF) patients. Nevertheless, the impact of these agents on ventricular arrhythmias (VAs) has not been thoroughly investigate...

Full description

Saved in:
Bibliographic Details
Main Authors: Miao Lin, Shiyu Zhang, Lu Zhang, Chengying Yang, Yang Luo, Yajin Peng, Xiaoqiu Tan, Qiang Wen, Xinrong Fan, Xianhong Ou
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Systematic Reviews
Subjects:
Heart failure
SGLT2 inhibitor
Sudden cardiac death
Ventricular arrhythmias
Meta-analysis
Online Access:https://doi.org/10.1186/s13643-025-02766-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13643-025-02766-7

Similar Items